These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3137743)

  • 1. [Preventive and therapeutic action of sera to the Re mutant of Salmonella minnesota in experimental generalized meningococcal infection].
    Mironova TK; Apollonin AV; Krokhina MA; Kostiukova NN; Likhoded VG
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Apr; (4):58-62. PubMed ID: 3137743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The protective activity of polyclonal and monoclonal antibodies to the lipopolysaccharide of Neisseria meningitidis serogroup A in in vivo experiments].
    Del'vig AA; Krasnoproshina LI; Volgareva GM; Bobyleva GV; Kuvakina VI; Artem'eva TA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Oct; (10):118-21. PubMed ID: 2127501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
    Nys M; Cloes JM; Demonty J; Joassin L
    J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.
    Pajon R; Buckwalter CM; Johswich KO; Gray-Owen SD; Granoff DM
    Vaccine; 2015 Mar; 33(11):1317-1323. PubMed ID: 25662856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
    Humbert MV; Christodoulides M
    Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.
    Tunheim G; Naess LM; Acevedo R; Fjeldheim ÅK; Bolstad K; García L; Cardoso D; Aase A; Zayas C; González H; Rosenqvist E; Norheim G
    Vaccine; 2014 Nov; 32(49):6631-8. PubMed ID: 25305564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of immunization with an enterobacterial vaccine on the rate of plating out of Shigella from the intestinal mucosa of mice orally infected].
    Apollonin AV; Elkina SI; Beĭlina VB; Likhoded VG; Sergeev VV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):24-8. PubMed ID: 3529760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serological heterogeneity of the immune response to the administration of a multicomponent meningococcal vaccine].
    Belova TN; Efimov DD
    Zh Mikrobiol Epidemiol Immunobiol; 1982 May; (5):94-8. PubMed ID: 6808793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Level of IgG antibodies to bacteria of 12 species in the blood sera of rabbits, immunized with preparations obtained from Neisseria meningitidis, grown under the stress conditions].
    Basnak'ian IA; Aleksakhina NN; Iastrebova NE; Vaneeva NP
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):14-9. PubMed ID: 16279527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine.
    Milagres LG; Gorla MC; Rebelo MC; Barroso DE
    FEMS Immunol Med Microbiol; 2000 Aug; 28(4):319-27. PubMed ID: 10891656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
    Noronha CP; Struchiner CJ; Halloran ME
    Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England.
    Ladhani SN; Giuliani MM; Biolchi A; Pizza M; Beebeejaun K; Lucidarme J; Findlow J; Ramsay ME; Borrow R
    Emerg Infect Dis; 2016 Feb; 22(2):309-11. PubMed ID: 26811872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.
    Beernink PT; Vianzon V; Lewis LA; Moe GR; Granoff DM
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin.
    Johns M; Skehill A; McCabe WR
    J Infect Dis; 1983 Jan; 147(1):57-67. PubMed ID: 6185599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects.
    DeMaria A; Johns MA; Berberich H; McCabe WR
    J Infect Dis; 1988 Aug; 158(2):301-11. PubMed ID: 3042872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective action of a vaccine made from Salmonella minnesota R 595 in the intranasal infection of mice with P. aeruginosa].
    Apollonin AV
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):73-7. PubMed ID: 6624314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG subclass antibodies to serogroup B meningococcal outer membrane antigens following infection and vaccination.
    Sjursen H; Wedege E; Rosenqvist E; Naess A; Halstensen A; Matre R; Solberg CO
    APMIS; 1990 Dec; 98(12):1061-9. PubMed ID: 2126441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants.
    Morley SL; Cole MJ; Ison CA; Camaraza MA; Sotolongo F; Anwar N; Cuevas I; Carbonero M; Campa HC; Sierra G; Levin M
    Pediatr Infect Dis J; 2001 Nov; 20(11):1054-61. PubMed ID: 11734711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of active and passive immunizations with lipid A and salmonella minnesota Re 595 on gram-negative infections in mice.
    Hodgin LA; Drews J
    Infection; 1976; 4(2):5-10. PubMed ID: 789248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.